数位治疗 (DTx) 市场规模、份额、收益分析、按产品、按收益模式、按应用、按分销管道、按地区 - 行业预测，2024-2031 年

数位治疗（DTx）的全球市场规模将于2022年达到34.4亿美元，预测期内（2024-2031年）复合年增长率为16.61%，从2023年到2031年的40.1亿美元。美国137.2 亿美元。

由于医疗保健技术的进步和慢性病盛行率的增加，全球数位治疗（DTx）市场正在迅速扩大。数位疗法 (DTx) 是软体驱动的主导，旨在透过基于证据和临床检验的治疗来治疗或管理医疗状况。这些解决方案用于管理各种健康状况，包括糖尿病、心血管疾病、呼吸道疾病和心理健康问题。替代或补充传统药物治疗的治疗方法，通常着重于行为改变、远端监测和患者教育。推动市场成长的关键因素包括对远距医疗服务的需求不断增长、行动医疗(行动医疗) 技术的日益采用以及基于价值的医疗保健模式的接受度不断提高。提高患者对数位疗法 (DTx) 治疗通讯协定的依从性，并提供即时资料见解，帮助个人更有效地管理自己的健康。政府和医疗保健提供者越来越认识到 DTx 在降低医疗成本和改善患者治疗效果方面的潜力。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 市场生态系统
• 主要投资分析
• 关键成功因素
• 竞争程度
• 技术分析
• 价值链分析
• 研发线产品分析
• 案例研究分析
• 监管环境
• 价格分析
• 专利分析

数位治疗 (DTx) 市场：依产品分类

• 市场概况
• 软体/平台
• 程式
• 虚拟实境/游戏

数位治疗 (DTx) 市场：按应用分类

• 市场概况
• 治疗/护理相关应用
  • 糖尿病
  • 中枢神经系统 (CNS) 疾病
  • 精神疾病
  • 其他中枢神经系统疾病
  • 禁止抽烟
  • 慢性呼吸道疾病
  • 肌肉骨骼疾病
  • 心血管疾病
  • 用药依从性
  • 胃肠道疾病
  • 復健和患者照护
  • 物质使用疾患与成瘾管理
  • 其他治疗/护理相关用途
• 预防性使用
  • 糖尿病前期
  • 肥胖
  • 营养
  • 生活方式管理
  • 其他预防用途

数位治疗 (DTx) 市场：按收益模式划分

• 市场概况
• 基于订阅的模式
• 一次性购买/年度授权模式
• 基于结果/价值的模型

数位治疗 (DTx) 市场：按销售管道

• 市场概况
• B2B销售管道
  • 付款人
  • 雇主
  • 製药公司
  • 提供者
  • 其他买家
• B2C销售管道
  • 看护者
  • 病人

数位治疗 (DTx) 市场规模：按地区

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• ANSYS（US）
• Dassault Systemes（SIMULIA）（France）
• PTC（Creo）（US）
• Siemens Digital Industries Software（Simcenter）（Germany）
• Autodesk（Simulation）（US）
• OpenFOAM（Open-source）（N/A）
• STAR-CCM+（US/Germany）
• COMSOL Multiphysics（Sweden）
• CD-adapco（STAR-CD, STAR-CCM+）（US/Germany）
• Altair（HyperWorks）（US）
• ESI Group（France）
• MSC Software（MSC Adams, MSC Marc）（US）
• MathWorks（MATLAB/Simulink）（US）
• Flow3D（US）
• Fluent（US）
• CONVECTION（US）
• Cadence Design Systems（US）
• Synopsys（US）
• Numerica（US）
• Pointwise（US）

Global Digital Therapeutics Market size was valued at USD 3.44 billion in 2022 and is poised to grow from USD 4.01 billion in 2023 to USD 13.72 billion by 2031, at a CAGR of 16.61 % during the forecast period (2024-2031).

Global digital therapeutics market is expanding rapidly, driven by technological advancements in healthcare and the increasing prevalence of chronic diseases. Digital therapeutics (DTx) are software-driven interventions designed to treat or manage medical conditions through evidence-based, clinically validated therapies. These solutions are used to manage a variety of health conditions, including diabetes, cardiovascular diseases, respiratory disorders, and mental health issues. They offer an alternative or complement to traditional drug treatments, often focusing on behavior modification, remote monitoring, and patient education. Key factors contributing to market growth include the rising demand for remote healthcare services, the increasing adoption of mobile health (mHealth) technologies, and the growing acceptance of value-based healthcare models. Digital therapeutics improve patient adherence to treatment protocols, provide real-time data insights, and empower individuals to manage their health more effectively. Governments and healthcare providers are increasingly recognizing the potential of DTx in reducing healthcare costs and improving patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Digital Therapeutics Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Digital Therapeutics Market Segmental Analysis

Global digital therapeutics market is segmented on the basis of offering, revenue model, application, sales channel, and region. By offering, market is segmented into software/platforms, programs, virtual reality/games. By revenue model, market is segmented into subscription-based model, one-time purchase/annual licensing model, and outcome /value-based model. By application, market is segmented into treatment/care-related applications, and preventive applications. By distribution channel, market is segmented into B2B sales channel, and B2C sales channel. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Digital Therapeutics Market

The growing prevalence of chronic diseases is a major driver for the digital therapeutics market. Conditions like diabetes, cardiovascular diseases, and obesity require continuous monitoring and management, often placing a strain on healthcare systems. Digital therapeutics offer a solution by providing personalized, scalable, and data-driven treatment plans that patient can access remotely. For example, mobile apps designed for diabetes management help patients track their glucose levels, adjust their diet, and maintain their medication schedule. As chronic diseases become more widespread due to aging populations and lifestyle factors, healthcare systems are turning to digital therapeutics as a cost-effective and efficient means to manage patient care. These tools not only help in monitoring the patient's condition but also support behavioral changes necessary for long-term disease management. By offering patients real-time feedback and continuous access to healthcare services, digital therapeutics are proving to be a valuable resource for managing chronic conditions.

Restraints in the Global Digital Therapeutics Market

One of the significant restraints in the digital therapeutics market is the complexity of the regulatory environment. Unlike traditional drugs and medical devices, digital therapeutics often fall into new or ambiguous categories, making it difficult for regulatory agencies like the FDA and EMA to establish clear approval guidelines. This regulatory uncertainty can delay product approvals and market entry, leading to longer development timelines and increased costs for companies. Moreover, the global nature of digital therapeutics presents additional challenges, as regulatory frameworks vary significantly from country to country. While some regions have established policies for digital health technologies, others are still developing regulatory mechanisms, creating hurdles for companies seeking to expand internationally. Concerns over patient data privacy, security, and compliance with healthcare regulations such as HIPAA also add to the complexity, making regulatory barriers one of the primary challenges in the market.

Market Trends of the Global Digital Therapeutics Market

The integration of artificial intelligence (AI) and machine learning (ML) technologies is a major trend in the digital therapeutics market. AI and ML enhance the capability of digital therapeutics by enabling the analysis of large volumes of patient data, thus facilitating more personalized treatment plans. These technologies can predict patient outcomes, optimize treatment regimens, and provide real-time interventions based on patient behavior and health metrics. For instance, AI-powered platforms for mental health can dynamically adjust therapy sessions based on patient responses, while AI in diabetes management tools can predict glucose level fluctuations and offer personalized recommendations. The ability to harness real-time data and predictive analytics improves the efficacy of digital therapeutics, making them more responsive to individual patient needs. As AI and ML technologies continue to advance, they are expected to further drive innovation and growth in the digital therapeutics sector, enhancing patient care and clinical outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Ecosystem of the Market
• Top Investment Analysis
• Key Success Factor
• Degree of Competition
• Technology Analysis
• Value Chain Analysis
• Pipeline Products Analysis
• Case Study Analysis
• Regulatory Landscape
• Pricing Analysis
• Patent Analysis

Digital Therapeutics Market by Offering

• Market Overview
• Software/Platforms
• Programs
• Virtual Reality/Games

Digital Therapeutics Market by Application

• Market Overview
• Treatment/Care-Related Applications
  • Diabetes
  • Central Nervous System (CNS) Disorders
  • Mental Health Disorders
  • Other CNS Disorders
  • Smoking Cessation
  • Chronic Respiratory Diseases
  • Musculoskeletal Disorders
  • Cardiovascular Diseases
  • Medication Adherence
  • Gastrointestinal Disorders
  • Rehabilitation & Patient Care
  • Substance Use Disorders & Addiction Management
  • Other Treatment/Care-Related Applications
• Preventive Applications
  • Prediabetes
  • Obesity
  • Nutrition
  • Lifestyle Management
  • Other Preventive Applications

Digital Therapeutics Market by Revenue Model

• Market Overview
• Subscription-Based Model
• One-Time Purchase/Annual Licensing Model
• Outcome /Value-Based Model

Digital Therapeutics Market by Sales Channel

• Market Overview
• B2B Sales Channel
  • Payers
  • Employers
  • Pharmaceutical Companies
  • Providers
  • Other Buyers
• B2C Sales Channel
  • Caregivers
  • Patients

Digital Therapeutics Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• ANSYS (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dassault Systemes (SIMULIA) (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PTC (Creo) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Digital Industries Software (Simcenter) (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Autodesk (Simulation) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OpenFOAM (Open-source) (N/A)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STAR-CCM+ (US/Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• COMSOL Multiphysics (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CD-adapco (STAR-CD, STAR-CCM+) (US/Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Altair (HyperWorks) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ESI Group (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MSC Software (MSC Adams, MSC Marc) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MathWorks (MATLAB/Simulink) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Flow3D (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluent (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CONVECTION (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cadence Design Systems (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synopsys (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Numerica (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pointwise (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments